No results for ‘’
Eiko Lifesciences Ltd
₹45.76
(0.31%)
Fri, 18 Sept 2026, 07:00 am
Process Industries
Chemicals: Specialty
24.5KEiko Lifesciences Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 39.91 | 37.17 | 37.17 | 36.74 | 36.23 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 |
| Public | 60.09 | 62.83 | 62.83 | 63.26 | 63.77 |
| Government | 0 | 0 | 0 | 0 | 0 |
Eiko Lifesciences Ltd Shareholding Pattern
The Eiko Lifesciences Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Eiko Lifesciences Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Eiko Lifesciences Ltd (NSE: , BSE: 540204) operates in the Process industries sector and Chemicals: specialty industry. Monitoring the Eiko Lifesciences Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Eiko Lifesciences Ltd Shareholding Pattern (Latest)
The latest Eiko Lifesciences Ltd shareholding for Mar 2026 is:
- Promoters: 39.91%
- FII: 0%
- DII: 0%
- Public: 60.09%
- Government: 0%
Promoter holding in Eiko Lifesciences Ltd has increased, indicating strong confidence from company promoters.
Eiko Lifesciences Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Eiko Lifesciences Ltd.
- Mar 2026: 39.91%
- Dec 2025: 37.17%
- Sept 2025: 37.17%
- Jun 2025: 36.74%
- Mar 2025: 36.23%
Promoter stake in Eiko Lifesciences Ltd has increased, indicating strong long-term confidence.
Eiko Lifesciences Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Eiko Lifesciences Ltd.
- Mar 2026: 0%
- Dec 2025: 0%
- Sept 2025: 0%
- Jun 2025: 0%
- Mar 2025: 0%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Eiko Lifesciences Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 0%
- Dec 2025: 0%
- Sept 2025: 0%
- Jun 2025: 0%
- Mar 2025: 0%
DII holdings remain stable, reflecting steady institutional participation.
Eiko Lifesciences Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 60.09%
- Dec 2025: 62.83%
- Sept 2025: 62.83%
- Jun 2025: 63.26%
- Mar 2025: 63.77%
Public holding remains stable with consistent retail participation.
Eiko Lifesciences Ltd Government Holding
Government holding in Eiko Lifesciences Ltd currently stands at 0%.
Eiko Lifesciences Ltd operates without significant government ownership.
Eiko Lifesciences Ltd Shareholding Analysis Summary
The Eiko Lifesciences Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Investors should monitor changes in Eiko Lifesciences Ltd shareholding for signals on institutional sentiment and ownership trends.
Regular monitoring of the Eiko Lifesciences Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.